A federal jury in Boston awarded $88 million to a man injured by a Medtronic hernia mesh in the first trial verdict of a major lawsuit claiming the company failed to warn physicians about the implant's rapid barrier degradation. The trial concluded August 4, 2026, after opening arguments in a bellwether case that will guide settlement negotiations for more than 10,000 pending lawsuits against the manufacturer. The verdict targets Covidien's Symbotex mesh, a product designed with a temporary collagen barrier to prevent bowels from adhering to the implant during healing. The jury found that Medtronic did not adequately communicate how quickly this protective layer could break down in some patients—a gap in warnings that injured the plaintiff and may affect how the company resolves thousands of similar claims.
Table of Contents
- What the jury decided
- How the mesh failed and what happened to the plaintiff
- What plaintiffs say Medtronic knew
- Scale of remaining litigation
- What comes next in the litigation
What the jury decided
On August 4, 2026, a federal jury found Medtronic's Covidien unit liable for failing to provide adequate warnings about rapid barrier degradation and awarded plaintiff Larry Patterson $77 million in damages and his wife $11 million in consortium damages. The $88 million total represents the largest verdict in over a dozen hernia mesh cases to proceed to trial. The jury did not award punitive damages and did not find fraud.
How the mesh failed and what happened to the plaintiff
Larry Patterson underwent hernia repair surgery in 2017 with a Covidien Symbotex mesh implant. The mesh's protective porcine collagen barrier degraded in approximately seven days—less than one-quarter of the 30-day timeframe physicians were told to expect.
Because the barrier broke down early, Patterson's bowels became obstructed and adhered to the mesh. During revision surgery in 2020, Patterson's surgeon removed portions of his small intestine that had fused to the mesh, requiring reconstruction. This injury and its surgical correction formed the basis of the damages claim that the jury awarded.
What plaintiffs say Medtronic knew
Plaintiffs' counsel argued at trial that Medtronic knew porcine collagen degraded faster than bovine versions but failed to warn physicians of adhesion risks. This allegation—that the company withheld information about performance differences between collagen types—formed the core of the liability finding. The jury accepted this theory without finding fraud, meaning the jury concluded that the lack of adequate warning was sufficient grounds for liability even without proof of intentional deception.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Scale of remaining litigation
Medtronic faces approximately 10,350 pending lawsuits over hernia mesh products. Of these, 7,450 are filed in Massachusetts state court and another 2,400 similar cases are consolidated in the federal multidistrict litigation (MDL 3029) before the same judge, Patti B.
Saris, who presided over Patterson's trial. The bellwether verdict will likely influence settlement discussions for many of these remaining cases. While $88 million is substantial, the absence of punitive damages and a fraud finding may limit how much higher settlements or verdicts rise in similar cases.
What comes next in the litigation
Now that a jury has rendered a verdict awarding damages based on inadequate warning, the court system typically uses such outcomes to guide settlement conferences and subsequent trials. Defendants can appeal the verdict, and the company may seek to reduce the award or challenge the jury's findings on appeal. Plaintiffs' attorneys will likely use this precedent to pursue similar claims in both state and federal courts.
You Might Also Like
- Forever chemicals found in strawberries sold nationwide, new lawsuit emerges
- Bellwether lawsuit: allegations Covidien concealed hernia mesh safety dangers
- Asbestos dangers explained: physician shares health risks and exposure consequences